Newsfeed Should PARP Inhibitors Have Tumor-Agnostic Approval Status? author Let's Win! Pancreatic Cancer 27 August, 2019 Listen to Maurie Markman, MD discuss PARP inhibitors. Watch here. . . Related Stories Newsfeed Immune Regulation of the cGAS-STING Signaling Pathway in the Tumor Microenvironment and Its Clinical ApplicationLet's Win! Pancreatic Cancer Newsfeed Identification of Tumor Antigens and Immune Subtypes of Pancreatic Adenocarcinoma for mRNA Vaccine DevelopmentLet's Win! Pancreatic Cancer Newsfeed Refining the Molecular Framework for Pancreatic Cancer with Single-Cell and Spatial TechnologiesLet's Win! Pancreatic Cancer